âThe scientific world of central nervous system (CNS) neuroinflammatory disorders in general and multiple sclerosis (MS) in particular continues to expand, and 2013 has witnessed interesting advances in many aspects of research. In this review we will discuss research discoveries and results that have contributed to expand our knowledge in diverse areas of the MS field, including new environmental and genetic risk factors, new lines of treatment, and biomarkers of treatment response. Finally, new data on diagnostic biomarkers for neuromyelitis optica (NMO) have emerged, in addition to advances in NMO treatment. Important advances in many aspects of multiple sclerosis (MS) research have been presented during 2013â Review on Recent Advances in Multiple Sclerosis and Related Disorders Tenembaum SN and Garrahan JP (2014).
This rapid growth in research and advancements in the area of multiple sclerosis was the thriving force behind the establishment of a new journal on Multiple Sclerosis in the year of 2014. The journal has a strong and highly active expert editorial board including the pioneering scientists and clinicians from the area of multiple sclerosis research. We are trying to make an interlink between various aspects of MS research and thus to bring the research findings from lab desk to bedside.
Last date updated on November, 2020